Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasudil in gene-specific ovarian cancer
NCT06890858Phase 2Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Apr 2025
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fasudil in ovarian cancer, sponsored by Zhejiang Provincial People's Hospital. Started Apr 2025; status: recruiting.
02
Drugs
fasudil
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT06890858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06890858.